Biomarkers and underlying mechanisms of vulnerability to depression
Depression is the leading chronic condition in Europe and fourth leading cause of mortality woldwide. Depression is twice more common in women compared with men, associated with dysregulation of steroid hormones in the HPA-HPG axi...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
HETODEP
Bringing the field of psychiatry forward Unraveling heterog...
100K€
Cerrado
SAF2008-05674-C03-03
ANALISIS DE PERFILES DE METILACION EN GENES INVOLUCRADOS EN...
91K€
Cerrado
TraumiR
microRNAs in susceptibility to traumatic stress
178K€
Cerrado
PID2021-127497OB-I00
CARACTERIZACION DE UN MODELO ANIMAL DE DEPRESION INTEGRANDO...
206K€
Cerrado
HealthyMom
Modelling and maintaining maternal mental health
2M€
Cerrado
MECPST-IPD
Identification of inflammation pathways involved in the pred...
222K€
Cerrado
Información proyecto VULDE
Líder del proyecto
Masarykova univerzita
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
146K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Depression is the leading chronic condition in Europe and fourth leading cause of mortality woldwide. Depression is twice more common in women compared with men, associated with dysregulation of steroid hormones in the HPA-HPG axis, ovarian dysfunction, obesity, and very recently, prenatal stress, but the mechanisms underlying its development are not well understood, yet. The current project aims to identify early hormonal and neuroimaging biomarkers and explain underlying mechanisms of vulnerability to depression. The use of novel methods in both neuroimaging and statistics on an extensive longitudinal dataset should make considerable progress possible.
The applicant is moving from the University of Nottingham, UK, to the Central European Institute of Technology (CEITEC), the Czech Republic to use data from clinicaly healthy young adults collected in the European Longitudinal Study of Children and Parents (ELSPAC). Her experience with population-based studies, neuroimaging, and psychoneuroendocrinology as well as her collaboration with Harvard Medical School and Rotman Research Institute at Baycrest in Toronto complement with the experitse of CEITEC researchers in structural, functional, and effective connectivity analyses. Enriching the ELSPAC dataset with neuroimaging and saliva samples will increase the potential of this unique study, and attract new collaborators and students. Having access to such a dataset as well as mastering the methods for studying brain connectivity would be an asset for applicant’s career development.